{"schema_version":"secwatch.filing_event.v1","accession":"0001093557-22-000142","form_type":"8-K","ticker":"DXCM","cik":"0001093557","company_name":"DEXCOM INC","filed_at":"2022-07-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.963756+00:00","generated_at":"2026-06-24T07:16:42.793149+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Dexcom Q2 revenue $696.2M (+17% YoY); GAAP EPS $0.12, Non-GAAP EPS $0.17","bullets":["Revenue $696.2M, +17% reported, +16% organic; U.S. +11%, international +39% reported (+34% organic).","GAAP operating margin 11.1% (down 590bps); Non-GAAP operating margin 14.6% (down 250bps).","GAAP net income $50.9M ($0.12 diluted EPS); Non-GAAP net income $69.5M ($0.17 diluted EPS).","FY2022 guidance: revenue $2.86-2.91B (17-19% growth); Non-GAAP gross margin ~65%, op margin ~16%, Adj. EBITDA ~25%.","Launched Dexcom ONE in UK/Spain; received CE Mark for G7 sensor algorithm; launched Spanish-language G6 app."],"urls":{"canonical":"https://secwatch.observer/filing/0001093557-22-000142","json":"https://secwatch.observer/filing/0001093557-22-000142.json","markdown":"https://secwatch.observer/filing/0001093557-22-000142.md","text":"https://secwatch.observer/filing/0001093557-22-000142.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1093557/000109355722000142/0001093557-22-000142-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1093557/000109355722000142/dxcm-20220728.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T07:16:42.793149+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}